KẾT CỤC THAI KỲ Ở CÁC THAI PHỤ MẮC BỆNH TIM SINH CON TRONG TAM CÁ NGUYỆT THỨ BA TẠI BỆNH VIỆN TỪ DŨ

Abstract

Objective: To describe clinical characteristics and identify factors associated with maternal and neonatal adverse outcomes among women with heart disease delivering at ≥28 weeks of gestation at Tu Du Hospital from January 2024 to December 2025.

Methods: A retrospective cross-sectional study was conducted on 366 medical records of pregnant women with heart disease. Factors associated with adverse outcomes were identified using multivariable logistic regression.

Results: Arrhythmias were the most common cardiac disorder (38.8%), and 71.9% of women were classified as mWHO risk class I–II. Adverse outcomes occurred in 20.8% of mothers and 9.8% of neonates. Cardiomyopathy (aOR = 2.9) and mWHO class ≥II (aOR = 2.2) were independently associated with adverse maternal outcomes. Maternal white blood cell count ≥15.0 K/µL (aOR = 11.9), fetal growth restriction (aOR = 4.3), and preterm birth <37 weeks (aOR = 15.2) were independently associated with adverse neonatal outcomes. Compared with the general obstetric population, women with heart disease had higher rates of preeclampsia, postpartum infection, cesarean delivery, preterm birth, and NICU admission (all p < 0.05).

Conclusion: Cardiomyopathy and mWHO class ≥II were independently associated with adverse maternal outcomes. Maternal white blood cell count ≥15.0 K/µL, fetal growth restriction, and preterm birth <37 weeks were independently associated with adverse neonatal outcomes.